The SDF-1 3′ a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: A study on Iranian multiple sclerosis patients

Journal of Molecular Neuroscience

Volumn 47, Issue 3, 2012, Pages 431-436

  Azin, Hossein ^a   Vazirinejad, Reza ^a   Ahmadabadi, Behzad Nasiri ^a   Khorramdelazad, Hossein ^a   Zarandi, Ebrahim Rezazadeh ^a   Arababadi, Mohammad Kazemi ^a   Karimabad, Mojgan Noroozi ^a   Shamsizadeh, Ali ^a   Rafatpanah, Houshang ^b   Hassanshahi, Gholamhossein ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Multiple sclerosis; Polymorphism; SDF 1 (CXCl12)

Indexed keywords

DNA; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; QUESTIONNAIRE;

ADULT; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; IRAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84863862064     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9672-6     Document Type: Article

References (31)

1. Arababadi MK, Hassanshahi G, Azin H, Salehabad VA, Araste M, Pourali R et al (2010a) No association between CCR5 D 32 mutation and multiple sclerosis in patients of south-eastern of Iran. Lab Med 41:31-33
2. Arababadi MK, Mosavi R, Khorramdelazad H, Yaghini N, Zarandi ER, Araste M et al (2010b) Cytokine patterns after therapy with Avonex(R), Rebif(R), Betaferon(R) and CinnoVex in relapsing-remitting multiple sclerosis in Iranian patients. Biomark Med 4 (5):755-759
3. Baker BJ, Akhtar LN, Benveniste EN (2009) SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 30(8):392-400
4. Corcione A, Casazza S, Ferretti E, Giunti D, Zappia E, Pistorio A et al (2004) Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A 101(30):11064-11069 (Pubitemid 38989584)
5. Derakhshan R, Arababadi MK, Ahmadi Z, Karimababadi MN, Salehabadi VA, Abedinzadeh M, et al (2011) Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients is correlated to disease state but is unrelated to polymorphism of the SDF-1β gene in the Iranian population. Inflammation [Epub ahead of print]
6. Giunti D, Borsellino G, Benelli R, Marchese M, Capello E, Valle MT et al (2003) Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol 73(5):584-590 (Pubitemid 38040470)
7. Hassanshahi G, Patel SS, Jafarzadeh AA, Dickson AJ (2007) Expression of CXC chemokine IP-10/Mob-1 by primary hepatocytes following heat shock. Saudi Med J 28(4):514-518 (Pubitemid 47046027)
8. Hassanshahi G, Rezvani ME, Arababadi MK, Shamsizadeh A, Mahmoodi M, Mousavi A et al (2009) Expression of regulated oncogen-alpha by primary hepatocytes following isolation and heat shock stimulation. Iran J Biotech 7(1):1-9
9. Hassanshahi G, Arababadi MK, Khoramdelazad H, Yaghini N, Zarandi ER (2010) Assessment of CXCL12 (SDF-1alpha) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in southeastern Iran. Arch Med Res 41(5):338-342
10. Hess DC, Borlongan CV (2008) Stem cells and neurological diseases. Cell Prolif 41(Suppl 1):94-114 (Pubitemid 350295855)
11. Kawasaki E, Ide A, Abiru N, Kobayashi M, Fukushima T, Kuwahara H et al (2004) Stromal cell-derived factor-1 chemokine gene variant in patients with type 1 diabetes and autoimmune thyroid disease. Ann N Y Acad Sci 1037:79-83 (Pubitemid 40299746)
12. Klein RS, Rubin JB (2004) Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. Trends Immunol 25(6):306-314 (Pubitemid 38610354)
13. Kohler RE, Comerford I, Townley S, Haylock-Jacobs S, Clark-Lewis I, McColl SR (2008) Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol 18(4):504-516
14. Li M, Ransohoff RM (2008) Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 84(2):116-131
15. Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441(7097):1094-1096 (Pubitemid 43990722)
16. Malik M, Chen YY, Kienzle MF, Tomkowicz BE, Collman RG, Ptasznik A (2008) Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1 alpha through Lyn kinase. J Immunol 181(7):4632-4637
17. McCandless EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH et al (2008) Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am J Pathol 172(3):799-808 (Pubitemid 351354551)
18. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121-127
19. O'Keeffe J, Gately CM, Counihan T, Hennessy M, Leahy T, Moran AP et al (2008) T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired. J Neurol Sci 275(1-2):22-28
20. Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ et al (2003) Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 170(4):2147-2152 (Pubitemid 36197438)
21. Patrussi L, Baldari CT (2011) The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection. Curr Med Chem 18(4):497-512
22. Poggi A, Catellani S, Fenoglio D, Borsellino G, Battistini L, Zocchi MR (2007) Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases. Curr Med Chem 14(30):3166-3170
23. Pourazar A, Salehi M, Jafarzadeh A, Arababadi MK, Oreizi F, Shariatinezhad K (2005) Detection of HBV DNA in HBsAg negative normal blood donors. Iran J Immunol 2(3):172-176
24. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J (2004) Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 18(1):29-40 (Pubitemid 38159436)
25. Razmkhah M, Doroudchi M, Ghayumi SM, Erfani N, Ghaderi A (2005) Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 49 (3):311-315 (Pubitemid 41139143)
26. Sellebjerg F, Bornsen L, Khademi M, Krakauer M, Olsson T, Frederiksen JL et al (2009) Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 73(23):2003-2010
27. Soriano A, Martinez C, Garcia F, Plana M, Palou E, Lejeune M et al (2002) Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3αA genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 186(7):922-931
28. Terasaki M, Sugita Y, Arakawa F, Okada Y, Ohshima K, Shigemori M (2011) CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target. Brain Tumor Pathol 28(2):89-97
29. Watanabe MA, de Oliveira Cavassin GG, Orellana MD, Milanezi CM, Voltarelli JC, Kashima S et al (2003) SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 35(1):31-34 (Pubitemid 36809187)
30. Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65(3):239-248
31. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M et al (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279(5349):389-393